Egis announces further investments at its Körmend site

Over the next few years, Egis Pharmaceuticals PLC will invest EUR 21.1 million to increase its capacity at its Körmend site. To finance these developments, Egis will use its own capital and a government subsidy of EUR 3.4 million – announced Csaba Poroszlai, CEO of Egis. In total, the company will devote more than EUR 50 million to the development of the Körmend site of Egis since 2019. More

From making elephant toothpaste to hunting ions

Elephant toothpaste, bouncy egg, ion hunting - spectacular experiments carried the show in the final of the Egis - Researcher’s Night National Chemistry Competition for Secondary School Students, held at the Egis Science and Technology Centre. Sometimes an immersive experience is enough to inspire more students to go in for chemistry, the basis for research and pharmaceutical drug development. However, the growing shortage of chemistry teachers is alarming. The best way to get youngsters interested in chemistry is through laboratory experiments, but they are often omitted, even in classes, held by specialised teachers. More

Commemorative plaque for Sándor Balla unveiled

We remembered the founder and chief executive officer of Egis’ predecessor More

Good results for Egis sailing boats in the Blue Ribbon race

On 14 July, more than 2,500 crew members on 516 boats set sail, taking part in the traditional Blue Ribbon regatta, in which the sailing section of Egis also successfully tackled the more than 150 km route around the lake.

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC

Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.

Dr István Hodász, former CEO of Egis becomes honorary citizen of Kőbánya

The recognition can be bestowed on a person who - through their activities, work, and attitude - has contributed to the development and growth of the district and thus raised the reputation of Kőbánya.